NDC11 83315010001
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 83315-0100-01 | 83315-0100 |
| 83315-0100-1 | 83315-0100 |
| 83315-100-01 | 83315-100 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 83315-100 | 83315-100-01 | E | Excluded after deficient or non-compliant submission was not corrected | excluded / ndc_excluded.zip | 367a005e9d99… | 383a685ebd0f… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| UDSx Medicated System | FUROSEMIDE, BENZALKONIUM CHLORIDE | Wellbeing Medical Supply | 8f1df75b-101a-45da-924a-2767c34a4efe | 2025-06-12 | Warnings, Adverse reactions | 83315-100-01 83315-100 83315010001 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.